Background. Little information is available regarding the demographic characteristics and outcomes of patients with prosthetic joint infection (PJI) resulting from gram-negative (GN) organisms, compared with patients with PJI resulting from gram-positive (GP) organisms.
Infection, one of the most devastating complications after total joint arthroplasty, is often associated with significant morbidity and increased medical costs [1] . Improvements in operative techniques, aseptic procedures, and the use of perioperative antibiotic prophylaxis have reduced the risk of prosthetic joint infection (PJI) to 1%-2% of patients at most medical centers [2] . However, despite these developments, the increasing number of joint replacement surgical procedures being performed has led to an increase in the number of cases of infection that need to be treated.
Treatment for PJI can be divided into 1 main groups:
(1) prosthesis removal with or without subsequent reimplantation and (2) debridement and implant retention using long-term antibiotics. Removal of all prosthesis components (ie, resection arthroplasty) has a higher chance of eradicating infection but requires extensive surgery and often prolonged immobilization [3] . Debridement and retention of the prosthesis is an attractive alternative, which may be attempted for selected patients to salvage the joint prosthesis [4] . This less-extensive surgery is thought to be associated with a lower probability of procedure-related morbidity, less immobilization, and, consequently, less need for rehabilitation. The main problem with debridement and retention, however, is that a substantial number of patients will ultimately experience a relapse of infection after this less-aggressive procedure, necessitating exchange or resection arthroplasty [3, 4] . The risk of failure for this type of treatment depends on a number of factors, including the causative organism(s) [5] [6] [7] [8] . Most PJIs are caused by gram-positive (GP) pathogens. Staphylococci (including Staphylococcus aureus and coagulase-negative staphylococci) and streptococci are among the most common organisms, constituting 65%-85% of all isolates. Gram-negative (GN) bacteria, which are less commonly associated with PJI, constitute 6%-23% of all episodes [9] [10] [11] [12] . Although GN infections constitute a relatively minor proportion of all PJIs, they are of significant clinical importance, because treatment of such infections is considered more complicated as a result of the virulence of the organisms, their growing resistance to antimicrobial agents, and the comorbid conditions of patients [6] [7] [8] .
Although there have been numerous reports regarding treatment of PJI, the comparison between GN and GP PJIs has not, to our knowledge, been reported in the English-language literature. The purposes of our retrospective comparative study were, therefore, to evaluate the demographic characteristics and outcomes of patients treated for GN PJI and to identify prognostic factors that would lead to treatment failure.
PATIENTS AND METHODS

Study design.
This was a retrospective case cohort study in which the surgical and medical treatment modalities of the patients were not randomized. Decisions of management were made by the treating physicians. The patients were observed from the date of diagnosis of PJI until treatment failure, final clinic visit, death, or loss to follow-up.
Study population. Our study included all patients with a diagnosis of PJI of the hip or knee who were treated at our institution during the period from January 2000 through December 2006. After approval was obtained from the institutional review board, patients were identified using the electronic database of the hospital, by matching them to the International Classification of Diseases, Ninth Revision, Clinical Modification, specific for PJI (code 996.66). Two independent researchers reviewed and confirmed the medical records. Only cases in which the first episode of PJI was treated at our institution were included in the analysis.
Definitions. A PJI was diagnosed if the same microorganism was recovered from at least 2 joint aspirate or intraoperative tissue specimens for culture or if at least one intraoperative culture was positive for the microorganism, plus if there was evidence of infection at the site of hip or knee prosthesis (ie, presence of a discharging sinus communicating with the joint, operative findings of purulence, or positive laboratory and histopathological test results) [13] . A GN PJI was defined as the presence of at least 1 GN pathogen at the site of infection, regardless of the total number of different strains. Treatment failure was defined as the occurrence of the following conditions at any time after the initial surgical procedure: (1) the presence of a PJI due to the original microorganism (relapse of infection) or a different strain (reinfection), (2) surgical findings of purulence around the joint or acute inflammatory histopathology on examination of periprosthetic tissues, (3) development of a sinus tract, or (4) death related to PJI.
We summarized the collected data (which included patient demographics, history of orthopedic surgery, comorbidities, presenting signs of PJI, duration of symptoms, laboratory findings, surgical and medical treatments, and bacteriologic results) at the time of study enrollment. GN and GP PJI data were analyzed and compared to determine risk factors and prognostic factors predicting outcomes.
Statistical analysis. As appropriate, a x 2 analysis or a Fisher exact test was used for analyzing categorical data. For numerical data, an independent t test or the nonparametric Mann-Whitney U test was used for between-group comparisons. The survival rate free of treatment failure was estimated using the Kaplan-Meier survival method and the log rank test. A P value of !.05 was considered to be statistically significant. All statistics were 2-sided and were performed using SAS software, version 9.1.3 (SAS).
RESULTS
Study population.
Fifty-three first-time episodes of GN PJI occurring among 50 patients from January 1, 2000, through December 31, 2006, were treated at our institution. This accounted for 53 (15%) of 346 first-time episodes of culturepositive PJI encountered during the study period (table 1) . Patients with GN PJI were older (median age, 68 vs. 59 years;
) and developed infection earlier after the index joint P ! .001 replacement surgery (median joint age, 74 vs. 109 days; P ! ) than did patients with GP PJI. Other risk factors for GN .001 PJI that approached statistical significance included fever ( ) and the presence of a sinus tract ( ). Pa-P p .09 P p .12 tients with GN PJI did not considerably differ from patients with GP PJI with regard to sex, joint location, multiple operations, polymicrobial infection, laboratory findings, underlying comorbidity, presence of pus in the joint, bacteremia, or type of surgical treatment modality.
Microbiologic findings. The microbiologic findings of the 53 episodes of GN PJI are outlined in table 2. A single microorganism was isolated in 51 episodes (96%), and multiple microorganisms were isolated in 2 episodes (4%). For patients with GN PJI, Pseudomonas aeruginosa was the most commonly isolated pathogen, involved in 21 episodes (19 monomicrobial and 2 polymicrobial episodes), followed next by Escherichia coli in 10 (19%) episodes and then by Klebsiella pneumoniae in 8 (15%) episodes.
Surgical and medical treatment. The most common initial surgical intervention for the treatment of GN PJI was debridement and retention of prosthesis, used in 27 (51%) episodes, followed by 2-stage exchange in 16 (30%) episodes and resection arthroplasty in 10 (19%) episodes. Debridement typically included complete surgical exposure of the joint, removal of the inflamed soft tissues and bone, and debridement of prosthetic-bone interfaces. Implantation of antibiotic-loaded cement beads within the joint was performed at the time of removal of the prosthesis and in 6 (22%) of the 27 episodes treated with debridement and retention. All patients with GN PJI received appropriate intravenous antimicrobial therapy that was based on the antimicrobial susceptibility pattern of the bacteria isolated from the intraoperative cultures (table 3) . The median duration of effective parenteral antibiotic therapy was 38 days (range, 24-52 days) for GN PJI episodes treated with debridement and retention of the components, 23 days (range, 6-36 days) for 2-stage exchange, and 17 days (range, 10-39 days) for episodes treated with resection arthroplasty. Patients with GN PJI who received debridement and retention were given additional oral antibiotic suppression for a median of 49 days (range, 28-92 days). Various regimens of oral antibiotic treatment were prescribed, including ciprofloxacin for 15 patients, clindamycin for 2 patients, a combination of both for 7 patients, and a combined therapy of ciprofloxacin, sulfamethoxazole, and trimethoprim for 3 patients.
Outcomes and prognostic factors. The 2-year survival rate free of treatment failure for patients with GN PJI was 27% (95% confidence interval [CI], 16%-34%) for debridement and retention, 87% (95% CI, 80%-99%) for 2-stage exchange, and 69% (95% CI, 59%-84%) for resection arthroplasty (figure 1). Patients with GN PJI who underwent debridement alone were significantly more likely to experience treatment failure than those who underwent 2-stage exchange ( ) and resection P ! .001 arthroplasty (
). P p .008 The outcomes of patients treated for GN PJI with 2-stage exchange and resection arthroplasty were similar to those of patients treated for GP PJI with similar surgical modalities: the 2-year estimates of the survival rate free of treatment failure for patients with GP PJI were 94% (95% CI, 86%-100%;
) for 2-stage exchange and 78% (95% CI, 70%-91%; P p .39 ) for resection arthroplasty. However, treating GN PJI P p .30 with debridement and retention of components was associat- ed with a lower 2-year cumulative survival rate free of treatment failure than treating GP PJI with debridement and retention of components (27% vs. 47% of episodes were successfully treated;
). P p .002
The potential risk factors leading to the differences between the subgroups of patients receiving debridement and retention are outlined in table 4. No risk factor was identified in terms of age, sex, joint location, duration of symptoms prior to surgery, multiple operations before PJI, polymicrobial infection, laboratory findings, durations of intravenous and oral antibiotic therapies, single antimicrobial medication, use of local antibiotic beads, underlying comorbidity, or presentation of PJI.
Of the 27 episodes of GN PJI occurring among 27 patients treated with debridement and retention, treatment failure was observed in 20 (74%) episodes. A total of 21 (78%) patients had their serum C-reactive protein levels decrease to half their pretreatment levels during antimicrobial therapy. However, of these 21 episodes, only 7 (33%) showed no evidence of recurrent infection, and 14 (67%) ultimately involved treatment failure during follow-up. A shorter duration of symptoms before treatment was associated with successful debridement in episodes of GN PJI (median duration of symptoms, 11 vs. 5 days; ) (table P p .02 5). No other risk factor for treatment failure was identified.
Mortality. Twenty-six patients had died during the course of writing this paper. Seven (5 patients with GP PJI and 2 with GN PJI) deaths were related to the infection. Other causes of death included complications secondary to liver cirrhosis (10 patients), underlying malignancy (6 patients), myocardial infarction (2 patients), and a traffic accident (1 patient).
DISCUSSION
The number of total joint replacement surgical procedures is increasing rapidly. It is estimated that, from 2005 to 2030, the number of primary total hip arthroplasties in the United States will increase by 174%, to 572,000 procedures per year, and new cases of total knee replacement will increase by 673%, to 3.48 million procedures per year [14] . Although the rate of infection after prosthetic joint replacement remains relatively constant, these large projected increases in demand for hip and knee replacements imply that the demand for treating patients with PJI is likely to increase. Although many authors have reported on the treatment of PJI of the hip or knee [4, 6, 9, 11, 12] , most of them dealt with infections resulting from a mixed group of microorganisms, with GP bacteria being the most common pathogens involved in these studies.
A number of difficulties occur during the treatment of bone and joint infections caused by GN bacteria. These difficulties occur primarily affect immunocompromised patients and are associated with treatment failure [6] [7] [8] ; only a limited number of experimental models have been described [15] , and randomized, controlled clinical trials are hampered by the fact that most institutions do not have a sufficient number of patients for such studies. We sought to report the demographic char- acteristics and treatment outcomes of patients with GN PJI and the prognostic factors associated with GN PJI. Data provided by the present study may help treating physicians identify patients at risk of acquiring GN infection and then make informed decisions (eg, regarding the selection of a broader empiric antimicrobial coverage after the surgery). These data might serve as a guide for predicting the outcome of such infections. Our data suggest that GN PJIs represent a substantial pro- portion of all occurrences of PJI. The proportion of episodes (53 [15%] of 346 episodes of PJI) that occurred in the present study is in conformity with those reported in the literature [9] [10] [11] [12] . We found that GN PJIs tend to occur more frequently among elderly patients and during the early postoperative period. Although not statistically significant, patients with GN PJI are more likely to have fever and develop a discharging sinus. We also found that patient with GN PJI who were treated with 2-stage exchange and resection arthroplasty had a favorable outcome comparable to that of patients with GP PJI who are treated with similar surgical modalities. However, in our study, the attempt to retain the prosthesis with debridement alone was associated with a significantly less favorable outcome for patients with GN PJI than for patients with GP PJI.
Table 4. Comparison of Episodes of Gram-Negative (GN) and Gram-Positive (GP) Prosthetic Joint Infection (PJI) Occurring among Patients Who Underwent Debridement and Retention of the Prosthesis
In an attempt to find the reason for the worse outcome of debridement and retention associated with GN PJI, we have compared the subgroups of patients with GN and GP PJI who underwent debridement surgery on the basis of a number of factors. However, with the numbers of patients available, no factors could be identified in terms of patients' demographic characteristics, surgical and medical treatment history, comorbidity, laboratory data, or presentation of infection. This finding mirrored the fact that the development of PJI as a result of a GN pathogen, in itself, might be an important factor contributing to the poor outcome of debridement and retention.
In an analysis of 99 episodes of PJI among patients who underwent debridement and retention, Marculescu et al [4] did not find GN infection to be associated with treatment failure. One explanation for this might be that only a small number of episodes of GN PJI (ie, 6 [6%] of 99 episodes) were included in their study; thus, their study lacked sufficient power to detect a difference.
In choosing between retention and removal of the prosthesis for the management of PJI, clinicians and patients are often forced to face a trade-off between short-term surgical morbidity and mortality and long-term relapse of infection. Patients sometimes ask to retain the prosthesis, under the misapprehension that a failed attempt at debridement causes little harm. This is a common clinical scenario. In fact, a failed attempt at debridement and retention of the prosthesis can result in the kind of morbidity associated with an orthopedic surgical procedure. It also consumes valuable healthcare resources, because further surgery is often required. We are not aware of any data from prospective clinical trials comparing prosthesis retention and removal for the treatment of PJI. Fisman et al [3] , using a Markov model to compare the cost-effectiveness of debridement and staged exchange in simulated patients, concluded that debridement and retention would provide greater quality-adjusted life expectancy gains than would 2-stage exchange arthroplasty among patients with infected hip after arthroplasty. However, this model was based on published studies in which GP microorganisms were the most common pathogens. The authors found that their results were most sensitive to the annual rate of relapse after debridement. Thus, their conclusion might not be applied properly to the episodes of GN PJI reported in our study, which resulted in a significantly higher rate of treatment failure.
Despite the dismal figure, debridement and retention of prosthesis was successfully attempted in 7 (26%) of 27 episodes of GN PJI. A short duration of symptoms before surgery was the only identified factor contributing to the success of treatment. In fact, in all of these episodes, the surgery was performed within 8 days after the onset of symptoms. These observations are consistent with outcome data from other cohorts of patients infected mainly by GP pathogens. Brandt et al [16] , in a study of 33 staphylococcal PJIs, reported that prostheses that were debrided more than 2 days after onset of symptoms were associated with a higher probability of treatment failure than were those debrided within 2 days of onset. For 34 patient in a retrospective study by Tattevin et al [12] , there were 13 patients (38%) who had a significantly short interval (!5 days) from onset of symptoms to debridement and were successfully treated, and there were 21 (62%) patients who had a much longer median interval (54 days) and experienced a failed debridement. Marculescu et al [4] reported that a duration of symptoms of у8 days was associated with a greater risk of treatment failure, higher by a factor of 2, after debridement and prosthesis retention. On the basis of the results of previous studies and the present study, we emphasize the importance of expedient debridement when attempting to salvage the prosthesis.
The presence of a sinus tract has been associated with treatment failure in previous reports [4, 17] . In our current study, given the small number of successful debridements for patients with GN PJI, we were unable to determine whether the presence of a sinus tract was a significantly poor prognostic factor ( ). Nevertheless, it is important to note that none P p .15 of the GN PJI episodes that were managed successfully involved patients who had a sinus tract.
Our study has several limitations. First, this is a retrospective study with all the potential drawbacks implicit in such a study design. Our institution is a tertiary care referral center with an established protocol for the treatment of PJI. Furthermore, in all cases, decisions were made in consultation with the infection specialists. Nonetheless, there remains the potential for uncontrolled selection bias among treating physicians. In addition, the number of GN PJIs included during the study period was relatively small, and thus our study may have lacked enough power to detect slight differences among subsets of patients. Finally, the quality of debridement among patients is likely to affect the outcome. However, it was very difficult to evaluate the quality of surgery, and thus we did not specifically address this variable in the present study.
In summary, GN PJI accounts for a substantial percentage of all PJI episodes. We believe that the choice of antimicrobial therapy for PJI should take into account the possibility of GN infection, especially in suspected patients who are older and who develop PJI early in the postoperative period. In comparison with PJI due to GP pathogens, GN PJI treated with 2-stage exchange and resection arthroplasty is associated with a comparatively favorable outcome. However, debridement and retention for GN PJI carries a higher rate of treatment failure and should be used sparingly among patients within the first few days after the onset of symptoms. Further data from randomized clinical trials are required to substantiate these findings.
